Skip to main content

Animations

MJFF Publications

5551 - 5560 of 6255 Results
Title
Year
  • Year
  • 2023
  • 2019
  • 2021
  • 2019
  • 2023
  • 2018
  • 2021
  • 2011
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 at a glance
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1242/jcs.259724
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.196
    Citation Count: 36
  • Summary Details
    OPEN
    Title: A comparison of prediction approaches for identifying prodromal Parkinson disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0256592
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Static magnetic field stimulation of the supplementary motor area modulates resting-state activity and motor behavior
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-019-0643-8
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-45078-3
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Post hoc analysis of the Exenatide‐PD trial—Factors that predict response
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.14096
    Best OA location URL:
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031
    Citation Count: 56
  • Summary Details
    OPEN
    Title: CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2022-330052
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29197
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.